Characteristics of the clinical pharmacists' interventions at the main general tertiary care hospital in Qatar

Medication-related problems (MRPs) are prevalent throughout healthcare systems, whereby pharmacy-based interventions are pivotal to reducing occurrence. In the Middle East, including Qatar, the professional roles of pharmacists have been expanding to improve patient safety. This study aimed to characterize and analyze pharmacist-led interventions among hospitalized patients in the leading general hospital in Qatar. A retrospective analysis of pharmacist interventions in the internal medicine ward, critical care unit, and emergency department (ED) was conducted. Data were extracted from three periods of 1 month (March 1–31, 2018, July 15–August 15, 2018, and January 1–31, 2019). A descriptive type of analysis was undertaken. A total of 340 patients with 858 interventions were analyzed. The average age of the study participants was 51 years (SD ± 17.7). The study population was predominantly male (65%). The prevailing pharmacist intervention was adding drug therapy (27%), followed by medication discontinuation (18%) and dosage adjustments (16%). This pattern was maintained across all subpopulations, e.g., gender, age, and ward, except for the ED, where cessation of medication was the most frequent intervention (4%). The two pharmacological classes associated with most interventions were anti-infective and cardiovascular agents. Pharmacist interventions effectively identify, prevent, and resolve MRPs in general inpatient settings in Qatar.


INTRODUCTION
Patient safety is a core objective of several national and international healthcare systems. 1,2Since the release of "To Err Is Human" by the Institute of Medicine (IOM), tremendous global efforts have been dedicated to ensuring the provision of optimum care to patients and minimizing the occurrence of medication-related problems (MRPs). 3he Pharmaceutical Care Network Europe (PCNE) has defined MRPs as "an event or circumstance involving drug therapy that actually or potentially interferes with desired health outcomes." 4The PCNE classified the causes of MRPs into nine domains: drug selection, drug form, dose selection, treatment duration, dispensing, drug use process, patientrelated, patient transfer-related, and others, e.g., no outcome monitoring. 4The most prevalent form of MRPs is medication errors, which could lead to patient harm, i.e., preventable adverse drug events (ADEs). 50][11][12][13] For instance, clinical pharmacybased interventions in the United States contributed to identifying and averting prescribing errors in 0.3%-1.9% of all medication orders. 135][16][17][18][19][20][21] In Qatar, there are two published attempts in relation to this aspect.The first focused on MRPs identified on discharge in four primary healthcare facilities, while the other focused on medication errors in neonatal intensive care units (NICUs). 22,23Aligning with international standards, the pharmacist role is substantially evolving in Qatar and is becoming more patientcentered.As the distribution of interventions varies between different settings, it is essential to investigate the clinical pharmacy interventions performed in the different settings and their Characteristics of the clinical pharmacists' interventions at the main general tertiary care hospital in Qatar emergency department (ED) of HGH during the study follow-up duration were eligible for inclusion in the study.The study sample followup of three periods of 1 month, i.e., March 1-31, 2018, July 15-August 15, 2018, and January 1-31, 2019.We included all interventional recommendations by clinical pharmacists or clinical pharmacy specialists on hospitalized patients.The clinical interventions are, initially, only suggestions for consideration by physicians, requiring their approval to be implemented in patient cases.Thus, only interventions that physicians accepted were included in our study without conducting content or quality assessment, as long as the intervention was revised and approved by the respective prescriber.Interventions reported by non-clinical pharmacists (staff/operational pharmacists) were excluded from this study.Staff pharmacists work in outpatient or inpatient pharmacies to verify or dispense medications.In contrast, clinical pharmacists work in inpatient settings alongside other healthcare providers to develop healthcare plans for hospitalized patients.Missing or incomplete data from the intervention sheet were obtained from the EPR system of the patient.

Outcomes
The primary outcome was to characterize clinical pharmacist interventions to prevent ADEs among patients admitted to the internal medicine, critical care, and emergency units of HGH.The interventions were categorized according to different characteristics (i.e., age, gender, medical disorder, pharmacological category, and hospital ward).

Data Extraction and Synthesis
The intervention details and relevant sociodemographic data were abstracted from the EPR system into a spreadsheet.Patients were classified according to the hospital ward, gender, and age [adults (18-

Sample Size
4][25] Our sample size was based on duration, and we believe that over 25% of the year (hence, 3 out of 12 months) is a sufficient sample size.To enhance the representativeness of our sample size, we included interventions reported during three nonconsecutive months to cover the period immediately after the annual staff performance evaluation (first month of the year), before the annual evaluation (last month of the year), and the middle between these.This is because the evaluation may influence the documentation of interventions by clinical pharmacists, whereby they may become more vigilant.

Statistical Analysis
Extracted data from patient records were populated into a data spreadsheet for descriptive analysis.The mean [± standard deviation (SD)] was calculated for continuous variables, while frequencies and percentages were calculated for categorical variables.

Characteristics of the Study Patients
During the 3-month study period, 340 participants were admitted to HGH, with 858 clinical pharmacy interventions included in this study.The mean age of the population was 51 years, and 65.3% were male.The majority of patients were Arab (55.3%), followed by Asian (non-Arab) (34.4%), primarily admitted to the general internal medicine unit (53.8%), followed by the emergency unit (30.88%)

Emergency Department (ED)
Clinical pharmacists working in the ED recorded 146 (17.0%) interventions out of 858 total included interventions in this study.Distinct from the order of interventions prevalence observed in the overall study population and all previously discussed subcategories, the prevailing intervention in the ED was discontinued medications (4.3%) (Table 2).The following types of change in resource use were the addition of another medication (3.9%), change in medication route (1.4%), decrease in dose (1.28%), and increase in dose (0.93%).Half of the vaccine recommendations were performed in the ED ward, and there were only two documentation instances of adding a prophylactic agent during hospitalization.Notably, most patients under this category were adults (n = 117) and males (n = 136), Tables 3A and 3B.Anti-infective agents continued to be the most commonly associated class with interventions (n = 28), followed by fluids and electrolytes (n = 20), cardiovascular medicines (n = 18), and GI medications (n = 14) (Appendix 2).

DISCUSSION
To our knowledge, this is the first study to describe clinical pharmacist-delivered interventions in an inpatient setting at a general tertiary hospital in Qatar.
Findings from this study indicated that adding another medication was the most frequent intervention.This differs from previously published studies, which reported dose adjustment as the predominant intervention. 10,21,25However, only some of these studies included the addition of drug therapy in their classifications.Consistent with our results, one study conducted in outpatient clinics showed that pharmacists were actively involved in adjusting patients' therapies, which included prescribing medications. 26This adds a new dimension to pharmacist duties, including identifying untreated conditions.In most published studies conducted in various settings and at different levels of care, including the present one, discontinuation of inappropriate prescription and dose alterations were featured high in the intervention categories.][27] Similar to previous studies, most interventions pertained to anti-infective agents and cardiovascular medications, possibly due to the frequency of prescribing these agents. 21,25,28djusting dose and cessation of medicines were the most prevalent interventions for errors with the anti-microbial agents.This is justifiable since three of the four most frequently identified agents require renal dosage adjustment, i.e., piperacillintazobactam, vancomycin, and meropenem. 6Of particular interest in our findings is that stopping an anti-infective agent was the prevailing intervention under this pharmacological class.This suggests that more efforts are required to plan and implement anti-microbial stewardship programs, especially since the widespread reliance on ceftriaxone, the third top agent in our study, has been reported in the literature to be the significant driver of cephalosporin resistance. 29mong cardiovascular medications, the addition of a prophylactic agent during hospitalization was frequently reported, primarily due to the need for low molecular weight heparin (LMWH) and UFH as venous thromboembolism (VTE) prophylaxis.
Although one would expect prophylaxis against VTE to be most prevalent in patients admitted to the ICU as they are at higher risk for VTE, our study showed that most prophylactic agents during hospitalization were added to patients in non-ICU settings.This could be due to the presence of ICU protocol in HGH and other hospitals worldwide that incorporated VTE prophylaxis as part of the initial assessment upon admission and in the follow-up daily rounds. 30OL. 2023 / ART.28 Characteristics of the clinical pharmacists' interventions at the main general tertiary care hospital in Qatar Our results reinforce the importance of pharmacistled medication reconciliation, a common practice in all hospitals under HMC, as medication initiation and discontinuation were frequently reported.Medication reconciliation programs are recognized as an effective method to tackle the burden of medication discrepancies and the subsequent potential patient harm that could occur during the transition of care. 11en though the addition of a vaccine is expected in older patients as more vaccines are recommended to this age group, e.g., flu vaccine and pneumococcal polysaccharide vaccine, most vaccination recommendations in our study were in younger adults. 30This could be attributed to the presence of national-level vaccination campaigns and the home health service in Qatar that follows up with elderly patients and ensures that they are up-to-date with their vaccines.
As fluctuations in glucose levels are anticipated in hospitalized patients owing to stress and changes in medications and diet, insulin was the single agent with the highest frequency of interventionrequiring errors. 31The most prevalent intervention for insulin was the change in the prescribed dose.
Medications associated with interventions in ICU patients were distinct from what has been identified in the overall population.Fluids and electrolytes were the second most cited class.
Previous studies elucidated our results by demonstrating that fluid and electrolyte imbalances are among the most encountered medical disorders in critically ill patients. 32Another noteworthy finding in our study was obtained from the ED, which reported medication discontinuation as the dominant intervention.This differs from other studies investigating interventions in the ED, where drug information inquiry and dosage modifications were more common.[35] It is also noteworthy that the male and female subcategories needed to be more balanced.This, however, could be considered representative of Qatar's population as the latest demographical statistics in the country illustrated that approximately 76% of the population consisted of males. 36is study has limitations that should be acknowledged.The study design is retrospective, which has the inherent limitation of possibly less-than-perfect documentation of interventions.
In addition, all interventions that satisfied the eligibility criteria were included without running a quality appraisal for their content, where we assumed that the interventions were inherently validated as they were reviewed by the intervening pharmacist and the physician who approved them.
Overall, however, this study still provides crucial information on the prevalence and nature of MRPs and the extent of the clinical pharmacist's role in preventing ADEs.Additionally, findings from this research should be shared with prescribers to highlight the issue of ADEs, which will help them reflect on their current practices and subsequently take measures to reduce the occurrence of ADEs.
Overall, for future directions, there is a need for frequent clinical auditing of pharmacist interventions to ensure their quality and validity.Furthermore, maintaining, if not expanding, the pharmacist role with better coordination of care among healthcare professionals is necessary to ensure high-quality care to patients.

CONCLUSION
This retrospective analysis showed that clinical pharmacist interventions effectively identify, prevent, and resolve MRPs in hospitalized patients at the main general hospital in Qatar.The prevailing pharmacist intervention was the addition of a medication, followed by medication discontinuation and dose adjustments.This pattern was maintained across all subcategories except for the ED, where cessation of medication was the most frequently identified.

APPENDICES
64 years old) and elderly (≥65 years old)].To categorize the pharmacy clinical interventions, the authors developed a comprehensive data collection sheet that classifies interventions into 18 types to capture all the possible interventions that a clinical pharmacist could suggest.

Prevalence of the Different Types of Clinical Pharmacy Interventions
(5.7%) (Table2).The addition of a culture test was only identified in the elderly female group, while five out of six vaccine interventions were in adult male patients.Out of 50 formulation change interventions, 35 were from intraventricular (IV) to oral (PO) route, seven were from nasogastric tube (NGT) to PO, five were recommending an alternative therapy that is in the formulary (in cases where the physician prescribed a non-formulary medication), and one of each of PO to NGT, PO to different PO formulation, and PO to patch.

Table 2 . The distribution of pharmacy interventions according to age, gender, and hospital ward.
), vancomycin (n = 22), ceftriaxone (n = 19), and meropenem (n = 16).thetop identified agent (n = 27), followed by 13 interventions for both dalteparin and unfractionated heparin (UFH).Discontinuation of medication was reported in 17.2% of interventions VOL.2023 / ART.28 Characteristics of the clinical pharmacists' interventions at the main general tertiary care hospital in Qatar Figure 1.Classes of medications implicated in errors.underthis drug category, followed by the addition of a prophylactic agent (16.4%).

Table 2
).Unlike the interventions obtained from general internal medicine units, the increase in medication dose (4%) was more common than the decrease in the dose (2.5%).Only five interventions were about the addition of a

Table 3 . (Cont.)
3B.The distribution of pharmacy interventions according to gender versus hospital ward.Characteristics of the clinical pharmacists' interventions at the main general tertiary care hospital in Qatar prophylactic agent during hospitalization, and two were for each of the decrease in medication duration and the addition of a vaccine, while only one intervention reported an addition of a culture test.